![](/img/cover-not-exists.png)
Cost-effectiveness of gefitinib, icotinib, and pemetrexed-based chemotherapy as first-line treatments for advanced non-small cell lung cancer in China
Lu, Shun, Ye, Ming, Ding, Lieming, Tan, Fenlai, Fu, Jie, Wu, BinVolume:
8
Language:
english
Journal:
Oncotarget
DOI:
10.18632/oncotarget.14310
Date:
February, 2017
File:
PDF, 2.11 MB
english, 2017